题名 | Progression-free survival versus overall survival as the primary end point in anticancer drug trials: Increasingly relevant impact of therapy following progression |
作者 | Maurie Markman |
杂志 | January 2009, Volume 11, Issue 1, pp 1-2 |
链接 | http://link.springer.com/article/10.1007%2Fs11912-009-0001-y |
欢迎光临 科研速递论坛 (http://www.expaper.cn/) | Powered by Discuz! X2.5 |